Crossmark

Salsalate: a pleotropic anti-inflammatory drug in the treatment of diabetes, obesity, and metabolic diseases

Published Online: 2023-09-27

Published Print: 2023-12

Authors

Hasan, I.

Rainsford, K. D.

Ross, Joel S. https://orcid.org/0000-0002-1088-0449
License Information

Text and Data Mining valid from 2023-09-27

Version of Record valid from 2023-09-27
More Information

Article History

Received: 17 March 2023

Accepted: 12 April 2023

First Online: 27 September 2023

Declarations

:

: None for all authors.

: Not applicable.

: Not applicable.

Document is current